馬医療市場 製品別(医薬品、ワクチン、薬用飼料添加物、診断薬、その他)、適応症別(筋骨格系障害、寄生虫駆除、馬ヘルペスウイルス、馬脳脊髄炎、馬インフルエンザ、西ナイルウイルス、破傷風、狂犬病、その他)、流通チャネル別(動物病院・診療所、小売薬局・ドラッグストア)、地域別 2024-2032

馬医療市場 製品別(医薬品、ワクチン、薬用飼料添加物、診断薬、その他)、適応症別(筋骨格系障害、寄生虫駆除、馬ヘルペスウイルス、馬脳脊髄炎、馬インフルエンザ、西ナイルウイルス、破傷風、狂犬病、その他)、流通チャネル別(動物病院・診療所、小売薬局・ドラッグストア)、地域別 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A24823

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Equine Healthcare Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Drugs
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Anti-Inflammatory Drugs
           6.1.2.2 Parasiticide Drugs
           6.1.2.3 Others
        6.1.3 Market Forecast
    6.2    Vaccines
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Live Attenuated Vaccine
           6.2.2.2 Recombinant Vaccine
           6.2.2.3 Others
        6.2.3 Market Forecast
    6.3    Medicated Feed Additives
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Diagnostics
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Indication 
    7.1    Musculoskeletal Disorders
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Parasite Control
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Equine Herpes Virus
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Equine Encephalomyelitis
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Equine Influenza
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    West Nile Virus
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Tetanus
        7.7.1 Market Trends
        7.7.2 Market Forecast
    7.8    Rabies
        7.8.1 Market Trends
        7.8.2 Market Forecast
    7.9    Others
        7.9.1 Market Trends
        7.9.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Veterinary Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies and Drug Stores
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  Drivers, Restraints, and Opportunities
    10.1    Overview
    10.2    Drivers
    10.3    Restraints
    10.4    Opportunities
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Boehringer Ingelheim International GmbH
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 SWOT Analysis
        14.3.2    Ceva
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 SWOT Analysis
        14.3.3    Dechra Pharmaceuticals PLC
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Elanco Animal Health Incorporated
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Esaote SpA
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 SWOT Analysis
        14.3.6    Hallmarq Veterinary Imaging
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 SWOT Analysis
        14.3.7    IDEXX Laboratories Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Merck & Co. Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Vetoquinol S.A.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Zoetis Inc
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

馬医療市場 製品別(医薬品、ワクチン、薬用飼料添加物、診断薬、その他)、適応症別(筋骨格系障害、寄生虫駆除、馬ヘルペスウイルス、馬脳脊髄炎、馬インフルエンザ、西ナイルウイルス、破傷風、狂犬病、その他)、流通チャネル別(動物病院・診療所、小売薬局・ドラッグストア)、地域別 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials